(lp0
S'STML INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a ... Yahoo Finance - Feb 10, 2017 NEW YORK, March 13, 2017 /PRNewswire/ -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Stemline Therapeutics, Inc.'
p1
aS'SHAREHOLDER ALERT: Levi &amp; Korsinsky, LLP Reminds Shareholders It Has Filed a ... Business Wire  - Feb 6, 2017 or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at  363-7500, toll-free:  363-5972. There is no cost or obligation to you.'
p2
aS"ALERT: Rosen Law Firm Reminds Stemline Therapeutics, Inc. Investors of ... Yahoo Finance - Mar 13, 2017 NEW YORK, March 13, 2017  -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Stemline Therapeutics, Inc. securities :  pursuant and/or traceable to Stemline's secondary public offering on or about&nbsp;...Rosen Law Firm Reminds Facebook, Inc. Investors of Important Deadline in Class ... - ForexTV.com"
p3
aS'Why Stemline Therapeutics Inc Stock Is Climbing Today Motley Fool - Jan 6, 2017 The biotech stock rollercoaster known as Stemline Therapeutics Inc  popped Friday morning with a 21.8% gain, and it was still up about 14.5% as of 11:44 a.m.Stemline Therapeutics  Spikes after announcing FDA Agreement - Economic Calendar'
p4
aS"Newman Ferrara LLP Announces Corporate Governance Investigation of Stemline ... Yahoo Finance - Feb 14, 2017 Newman Ferrara LLP announced today that the firm is conducting an investigation on behalf of shareholders of Stemline Therapeutics Inc.   into potential breaches of fiduciary duty by the Company's Board of Directors ..."
p5
aS"Here's Why Stemline Therapeutics Stock Fell 36.9% This Morning Motley Fool - Feb 2, 2017 Shares of Stemline Therapeutics  tumbled nearly 37% this morning after investors learned that a patient died in a clinical trial involving its lead drug candidate, SL-401.Side Effect Kills Cancer Patient in Stemline Therapeutics Drug Trial; Company ... - TheStreet.com"
p6
aS'Kirby McInerney LLP Advises Stemline Therapeutics, Inc. Investors of Potential ... Yahoo Finance - Feb 6, 2017 The law firm of Kirby McInerney LLP announced today that a class action lawsuit has been filed in the United States District Court for the Southern District of New York against Stemline Therapeutics, Inc.   on behalf ...'
p7
aS'Stemline Therapeutics to Present at the 29th Annual ROTH Conference GlobeNewswire  - Feb 21, 2017 NEW YORK, March 10, 2017  -- Stemline Therapeutics, Inc. , a clinical-stage biopharmaceutical company developing novel therapeutics for oncology indications of unmet medical need, announced today that Ivan&nbsp;...Stemline Therapeutics Inc.  Soars 7.98% on March 09 - Equities.comStemline Therapeutics  Reaches $9.70 After 4.00% Up Move, 0 Analysts ... - HuronReport'
p8
aS'Wolf Popper LLP Announces Investigation on Behalf of Investors in Stemline ... Yahoo Finance - Feb 27, 2017 27, 2017 /PRNewswire/ -- Wolf Popper LLP is investigating potential securities fraud claims on behalf of investors in Stemline Therapeutics, Inc. securities  during the period January 6, 2017 through February 1, 2017. Such investors are advised ...'
p9
aS'Robbins Geller Rudman &amp; Dowd LLP Files Class Action Suit Against Stemline ... Yahoo Finance - Feb 10, 2017 SAN DIEGO, Feb. 10, 2017 /PRNewswire/ -- Robbins Geller Rudman &amp; Dowd LLP   today announced that a class action has been commenced on behalf of purchasers of Stemline Therapeutics, Inc.Robbins Geller Rudman &amp; Dowd LLP Announces Proposed Settlement of Revance ... - PR Newswire '
p10
a.